The same association between circulating GDF15 levels and body weight loss was observed in an independent cohort of advanced metastatic NSCLC, suggesting that this association is agnostic of disease stage, and further corroborating the key role of GDF15 as a mediator of CAC in NSCLC. The gene discussed is GDF15; the disease is non-small cell lung carcinoma.